Find Dihydroergotoxine Mesylate manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

ACTIVE PHARMA INGREDIENTS

0

CEP/COS

CEP/COS Certifications

0

JDMF

JDMFs Filed

0

EU WC

EU WC

0

KDMF

KDMF

0

VMF

NDC API

API REF. PRICE (USD/KG)

$
$ 0

MARKET PLACE

0

API

0

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

0

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Listed Dossiers

Listed Dossiers

0 DRUGS IN DEVELOPMENT

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

0

EDQM

0

JP

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

0

Health Canada Patents

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

GLOBAL SALES INFORMATION

Annual Reports

NA

Finished Drug Prices

NA

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: Ergoloid-mesylates, Ergoloid_mesylate, Chebi:181460, Nicotinebi-l-(+)-tartrate, 12'-hydroxy-2'-isopropyl-3',6',18-trioxo-5'-tert-pentyl-9,10-dihydroergotaman #, N-[2-hydroxy-7-(2-methylbutan-2-yl)-5,8-dioxo-4-propan-2-yl-3-oxa-6,9-diazatricyclo[7.3.0.02,6]dodecan-4-yl]-7-methyl-6,6a,8,9,10,10a-hexahydro-4h-indolo[4,3-g]quinoline-9-carboxamide
Molecular Formula
C33H45N5O5
Molecular Weight
591.7  g/mol
InChI Key
YLXBZBPHTNJZQE-UHFFFAOYSA-N

Dihydroergotoxine Mesylate
1 2D Structure

Dihydroergotoxine Mesylate

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
N-[2-hydroxy-7-(2-methylbutan-2-yl)-5,8-dioxo-4-propan-2-yl-3-oxa-6,9-diazatricyclo[7.3.0.02,6]dodecan-4-yl]-7-methyl-6,6a,8,9,10,10a-hexahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide
2.1.2 InChI
InChI=1S/C33H45N5O5/c1-7-31(4,5)27-29(40)37-13-9-12-25(37)33(42)38(27)30(41)32(43-33,18(2)3)35-28(39)20-14-22-21-10-8-11-23-26(21)19(16-34-23)15-24(22)36(6)17-20/h8,10-11,16,18,20,22,24-25,27,34,42H,7,9,12-15,17H2,1-6H3,(H,35,39)
2.1.3 InChI Key
YLXBZBPHTNJZQE-UHFFFAOYSA-N
2.1.4 Canonical SMILES
CCC(C)(C)C1C(=O)N2CCCC2C3(N1C(=O)C(O3)(C(C)C)NC(=O)C4CC5C(CC6=CNC7=CC=CC5=C67)N(C4)C)O
2.2 Synonyms
2.2.1 Depositor-Supplied Synonyms

1. Ergoloid-mesylates

2. Ergoloid_mesylate

3. Chebi:181460

4. Nicotinebi-l-(+)-tartrate

5. 12'-hydroxy-2'-isopropyl-3',6',18-trioxo-5'-tert-pentyl-9,10-dihydroergotaman #

6. N-[2-hydroxy-7-(2-methylbutan-2-yl)-5,8-dioxo-4-propan-2-yl-3-oxa-6,9-diazatricyclo[7.3.0.02,6]dodecan-4-yl]-7-methyl-6,6a,8,9,10,10a-hexahydro-4h-indolo[4,3-g]quinoline-9-carboxamide

2.3 Create Date
2005-03-27
3 Chemical and Physical Properties
Molecular Weight 591.7 g/mol
Molecular Formula C33H45N5O5
XLogP33.5
Hydrogen Bond Donor Count3
Hydrogen Bond Acceptor Count6
Rotatable Bond Count5
Exact Mass591.34206955 g/mol
Monoisotopic Mass591.34206955 g/mol
Topological Polar Surface Area118 Ų
Heavy Atom Count43
Formal Charge0
Complexity1180
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count7
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1

Digital Content read-more

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

Global Sales Information

Do you need Business Intel? Ask us

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

ABOUT THIS PAGE

Dihydroergotoxine Mesylate Manufacturers

A Dihydroergotoxine Mesylate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Dihydroergotoxine Mesylate, including repackagers and relabelers. The FDA regulates Dihydroergotoxine Mesylate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Dihydroergotoxine Mesylate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

click here to find a list of Dihydroergotoxine Mesylate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.

Dihydroergotoxine Mesylate Suppliers

A Dihydroergotoxine Mesylate supplier is an individual or a company that provides Dihydroergotoxine Mesylate active pharmaceutical ingredient (API) or Dihydroergotoxine Mesylate finished formulations upon request. The Dihydroergotoxine Mesylate suppliers may include Dihydroergotoxine Mesylate API manufacturers, exporters, distributors and traders.

click here to find a list of Dihydroergotoxine Mesylate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.

Dihydroergotoxine Mesylate USDMF

A Dihydroergotoxine Mesylate DMF (Drug Master File) is a document detailing the whole manufacturing process of Dihydroergotoxine Mesylate active pharmaceutical ingredient (API) in detail. Different forms of Dihydroergotoxine Mesylate DMFs exist exist since differing nations have different regulations, such as Dihydroergotoxine Mesylate USDMF, ASMF (EDMF), JDMF, CDMF, etc.

A Dihydroergotoxine Mesylate DMF submitted to regulatory agencies in the US is known as a USDMF. Dihydroergotoxine Mesylate USDMF includes data on Dihydroergotoxine Mesylate's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Dihydroergotoxine Mesylate USDMF is kept confidential to protect the manufacturer’s intellectual property.

click here to find a list of Dihydroergotoxine Mesylate suppliers with USDMF on PharmaCompass.

Dihydroergotoxine Mesylate NDC

National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Dihydroergotoxine Mesylate as an active pharmaceutical ingredient (API).

Finished drug products

The FDA updates the NDC directory daily. The NDC numbers for Dihydroergotoxine Mesylate API and other APIs are published in this directory by the FDA.

Unfinished drugs

The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.

Pharmaceutical companies that manufacture Dihydroergotoxine Mesylate as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.

Compounded drug products

The NDC directory also contains data on finished compounded human drug products that contain Dihydroergotoxine Mesylate and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Dihydroergotoxine Mesylate NDC to their finished compounded human drug products, they may choose to do so.

click here to find a list of Dihydroergotoxine Mesylate suppliers with NDC on PharmaCompass.

Dihydroergotoxine Mesylate GMP

Dihydroergotoxine Mesylate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.

GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).

PharmaCompass offers a list of Dihydroergotoxine Mesylate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Dihydroergotoxine Mesylate GMP manufacturer or Dihydroergotoxine Mesylate GMP API supplier for your needs.

Dihydroergotoxine Mesylate CoA

A Dihydroergotoxine Mesylate CoA (Certificate of Analysis) is a formal document that attests to Dihydroergotoxine Mesylate's compliance with Dihydroergotoxine Mesylate specifications and serves as a tool for batch-level quality control.

Dihydroergotoxine Mesylate CoA mostly includes findings from lab analyses of a specific batch. For each Dihydroergotoxine Mesylate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.

Dihydroergotoxine Mesylate may be tested according to a variety of international standards, such as European Pharmacopoeia (Dihydroergotoxine Mesylate EP), Dihydroergotoxine Mesylate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Dihydroergotoxine Mesylate USP).

Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty